Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide

The review is devoted to the pharmacological effects, the results of clinical trials, safety and the research perspectives of the first incretinomimetic exenatide

Guardado en:

Detalles Bibliográficos
Autores principales:	Alexander Sergeevich Ametov, Lyudmila Leonidovna Kamynina
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2011
Materias:	diabetes mellitus incretin glucagon-like peptide exenatide Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/39a63267edfd4f62849f4191ed63ee32
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:39a63267edfd4f62849f4191ed63ee32
record_format	dspace
spelling	oai:doaj.org-article:39a63267edfd4f62849f4191ed63ee322021-11-14T09:00:16ZPharmalogical effects and results of clinical trials of the first incretinomimetic exenatide2072-03512072-037810.14341/2072-0351-6226https://doaj.org/article/39a63267edfd4f62849f4191ed63ee322011-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6226https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The review is devoted to the pharmacological effects, the results of clinical trials, safety and the research perspectives of the first incretinomimetic exenatideAlexander Sergeevich AmetovLyudmila Leonidovna KamyninaEndocrinology Research Centrearticlediabetes mellitusincretinglucagon-like peptideexenatideNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 3, Pp 63-68 (2011)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus incretin glucagon-like peptide exenatide Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus incretin glucagon-like peptide exenatide Nutritional diseases. Deficiency diseases RC620-627 Alexander Sergeevich Ametov Lyudmila Leonidovna Kamynina Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
description	The review is devoted to the pharmacological effects, the results of clinical trials, safety and the research perspectives of the first incretinomimetic exenatide
format	article
author	Alexander Sergeevich Ametov Lyudmila Leonidovna Kamynina
author_facet	Alexander Sergeevich Ametov Lyudmila Leonidovna Kamynina
author_sort	Alexander Sergeevich Ametov
title	Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
title_short	Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
title_full	Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
title_fullStr	Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
title_full_unstemmed	Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
title_sort	pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
publisher	Endocrinology Research Centre
publishDate	2011
url	https://doaj.org/article/39a63267edfd4f62849f4191ed63ee32
work_keys_str_mv	AT alexandersergeevichametov pharmalogicaleffectsandresultsofclinicaltrialsofthefirstincretinomimeticexenatide AT lyudmilaleonidovnakamynina pharmalogicaleffectsandresultsofclinicaltrialsofthefirstincretinomimeticexenatide
_version_	1718429576533639168

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide

Ejemplares similares